Smart science to improve lives™
Croda Denmark

Denmark

Croda Denmark was formerly Brenntag Biosector (Biosector), acquired in 2019 and for more than 80 years has been dedicated to safe and effective adjuvants for use in human and veterinary vaccines. No other company can match our expertise in this area.

Our site at Frederikssund includes R&D, engineering, production QA/QC, administration, warehouse and distribution: 

  • World leading adjuvant specialist serving major human and veterinary vaccine producers
  • Industry leading R&D capabilities for a strong pipeline of innovative next generation vaccine adjuvants
  • Running the only aseptic and GMP certified manufacturing site for adjuvants globally

The combination of a passionate team, adjuvant expertise, industry-leading production facilities and a dedicated global sales network committed to understanding customer needs mean we can better serve our pharmaceutical customers through our classic portfolio and our rich development pipeline. We realise the vaccines and blood products of tomorrow require new and innovative adjuvants, so our R&D department is focused on the next generation of adjuvants.

Croda Denmark

Elsenbakken 23
3600 Frederikssund
Denmark
sustainable innovation plants in a lab

About us

We are the name behind high performance ingredients and technologies in some of the most successful brands in the world.

Croda Formulator at work in labs

Where we operate

Every day our global team, across 37 countries, work together to inspire our customers.

Further reading

Croda develops young minds of tomorrow during COP26

We have launched new sustainability focused materials for children in STEM

Read more
Climate positive

Transition to a dedicated Consumer Care and Life Sciences company

Croda enters agreement to sell majority of Performance Technologies and Industrial Chemicals businesses; completing its transition into a dedicated Consumer Care and Life Sciences company

Read more

Appointment of Non-Executive Director

We are pleased to announce the appointment of Non-Executive Director, Nawal Ouzren.

Read more

Strategic review of Performance Technologies and Industrial Chemicals businesses

The core objective will be to establish what ownership structure best serves this part of Croda’s business going forward, to create a stronger platform for its future growth.

Read more